Literature DB >> 21528464

Accuracy of serum LDH elevation for the diagnosis of Pneumocystis jiroveci pneumonia.

Monika N Vogel1, Patrick Weissgerber, Benjamin Goeppert, Jürgen Hetzel, Mignon Vatlach, Claus D Claussen, Marius Horger.   

Abstract

In 328 immunocompromised patients, 105 with and 193 without Pneumocystis jiroveci pneumonia (PCP), serum lactate dehydrogenase (LDH) was analysed retrospectively, taking into consideration the time interval from the onset of symptoms to the start of specific therapy. 97 of the 105 PCP patients were negative for human immunodeficiency virus (HIV). Eight were positive. Of the 193 patients without PCP 134 were HIV-negative and 59 were HIV-positive. In HIV-negative patients the sensitivity of LDH elevation was 63% and specificity 43%. In HIV-positive patients sensitivity was 100% and specificity 47%. The overall accuracy of LDH for the diagnosis of PCP was 52%, 51% in HIV-negative and 58% in HIV-positive patients. Except for its sensitivity in HIV-positive patients, the value of LDH for the diagnosis of PCP should not be overestimated.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21528464     DOI: 10.4414/smw.2011.13184

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  13 in total

Review 1.  Infections in the immunosuppressed host.

Authors:  M Patricia George; Henry Masur; Karen A Norris; Scott M Palmer; Cornelius J Clancy; John F McDyer
Journal:  Ann Am Thorac Soc       Date:  2014-08

2.  Pneumocystis jirovecii pneumonia prophylaxis in a 42-year-old woman on immunosuppressive therapy.

Authors:  Sheliza Halani; Nisha Andany; Rupal Shah
Journal:  CMAJ       Date:  2020-10-26       Impact factor: 8.262

Review 3.  Diagnosing Pneumocystis jirovecii pneumonia: A review of current methods and novel approaches.

Authors:  Marjorie Bateman; Rita Oladele; Jay K Kolls
Journal:  Med Mycol       Date:  2020-11-10       Impact factor: 4.076

4.  (1-3)-beta-D-glucan in association with lactate dehydrogenase as biomarkers of Pneumocystis pneumonia (PcP) in HIV-infected patients.

Authors:  F Esteves; C-H Lee; B de Sousa; R Badura; M Seringa; C Fernandes; J F Gaspar; F Antunes; O Matos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-02-03       Impact factor: 3.267

Review 5.  Evaluation of respiratory disease.

Authors:  Sofya Tokman; Laurence Huang
Journal:  Clin Chest Med       Date:  2013-04-15       Impact factor: 2.878

6.  Test performance of blood beta-glucan for Pneumocystis jirovecii pneumonia in patients with AIDS and respiratory symptoms.

Authors:  Brian R Wood; Lauren Komarow; Andrew R Zolopa; Malcolm A Finkelman; William G Powderly; Paul E Sax
Journal:  AIDS       Date:  2013-03-27       Impact factor: 4.177

7.  Pneumocystis jirovecii dihydropteroate synthase gene mutations in a group of HIV-negative immunocompromised patients with Pneumocystis pneumonia.

Authors:  Yingjiao Long; Cheng Zhang; Li Su; Chengli Que
Journal:  Exp Ther Med       Date:  2014-10-03       Impact factor: 2.447

8.  Path of least resistance: how computerised provider order entry can lead to (and reduce) wasteful practices.

Authors:  Joseph Choi; Cori Rebecca Atlin
Journal:  BMJ Open Qual       Date:  2018-04-09

9.  Increased risk of refractory Mycoplasma pneumoniae pneumonia in children with atopic sensitization and asthma.

Authors:  Jeong Eun Shin; Bo Ram Cheon; Jae Won Shim; Deok Soo Kim; Hae Lim Jung; Moon Soo Park; Jung Yeon Shim
Journal:  Korean J Pediatr       Date:  2014-06-30

10.  Clinical characteristics of coronavirus disease (COVID-19) early findings from a teaching hospital in Pavia, North Italy, 21 to 28 February 2020.

Authors:  Marta Colaneri; Paolo Sacchi; Valentina Zuccaro; Simona Biscarini; Michele Sachs; Silvia Roda; Teresa Chiara Pieri; Pietro Valsecchi; Antonio Piralla; Elena Seminari; Angela Di Matteo; Stefano Novati; Laura Maiocchi; Layla Pagnucco; Marcello Tirani; Fausto Baldanti; Francesco Mojoli; Stefano Perlini; Raffaele Bruno
Journal:  Euro Surveill       Date:  2020-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.